In the Western world, LinkedIn is a staple for many recruitment professionals. It has proven to be a powerful tool for networking, talent sourcing and job postings. But in Japan, people don’t use LinkedIn very much.Here’s why LinkedIn isn’t popular…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS 8 of 10 Leading Drug Makers Report Declines in 1st-Half Sales
November 7, 2011
-
REGULATORY CSIMC Subcommittee Approves Proposal to Expand Range of Drugs Subject to Re-pricing
November 4, 2011
-
BUSINESS Eisai President Says Japan, China to Become Key Battlefields for Aricept
November 2, 2011
-
BUSINESS Marketing of Imusera, Telavic to Be Limited to Specialists at First: MTPC
November 2, 2011
-
BUSINESS DSP to Boost Domestic CNS Business for Early Maximization of Lonasen
November 1, 2011
-
BUSINESS Shionogi’s Strength in Japan Weakened by Slack US Results, Overall Sales Down 13.5% in Apr-Sept
November 1, 2011
-
BUSINESS DSP: Strong Yen Contributes to 5.6% Decline in Sales
November 1, 2011
-
REGULATORY Drug-induced Hepatitis Victims, Lawyers Petition Against Establishment of “Third Party Organization”
October 31, 2011
-
ACADEMIA JSGM Calls for Elimination of GE Drug Refusal Option in Prescriptions
October 28, 2011
-
REGULATORY Subcommittee to Recommend Use of Most-recent 3-Year Averages in Drug Cost Calculation
October 27, 2011
-
REGULATORY DPJ Lawmakers Opposed to TPP Criticize MHLW at Hearings
October 27, 2011
-
BUSINESS GSK CEO Thinks Highly of Premiums for New Drug Creation, Key to Attractive Market
October 26, 2011
-
REGULATORY Supreme Court Upholds Ban on Reimbursement in “Mixed Healthcare”
October 26, 2011
-
BUSINESS “Sales of Teribone Can Reach ¥10 Bil.”: President Asano of Asahi Kasei Pharma
October 25, 2011
-
BUSINESS Top Drug Makers Poised to Announce 1st-Half Results: Patent Expirations Could Have Big Impact
October 25, 2011
-
BUSINESS CMIC, Medipal Set Up Joint Venture for Orphan Drugs, Develop Alliance Model
October 24, 2011
-
REGULATORY Survey Finds Slight Increase in Generic Drug Dispensing Rate
October 24, 2011
-
BUSINESS Abbott to Separate into 2 Companies
October 21, 2011
-
BUSINESS Chugai Tops Patent Asset Rankings, Teijin Jumps to Second Place
October 21, 2011
-
REGULATORY MHLW Presents Data at Chuikyo Supporting Reduction in 70% Rule for New Generics
October 20, 2011
ページ
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…